The forkhead transcription factor Foxo3 is a master regulator and potent suppressor of primordial follicle activation. Loss of Foxo3 function in the mouse leads to premature ovarian failure (POF) due to global follicle activation. METHODS and RESULTS: Here, we show that the mouse Foxo3 locus is haploinsufficient, and that Foxo3 2/1 females undergo early reproductive senescence consistent with an increased rate of primordial follicle utilization. Then, to determine if heterozygous or homozygous polymorphisms or mutations of the human orthologue FOXO3 contribute to POF or idiopathic primary amenorrhea (PA), we sequenced the exons and flanking splice sequences of the gene in a large number of women with idiopathic POF (n 5 273) or PA (n 5 29). A total of eight single-nucleotide polymorphisms (SNPs) were identified, revealing a substantial amount of genetic variation at this locus. Allelic frequencies in control samples excluded several of these variants as causal. For the remaining variants, site-directed mutagenesis was performed to assess their functional impact. However, these rare sequence variants were not associated with significant decreases in FOXO3 activity. CONCLUSIONS: Taken together, our findings suggest that, despite the potential for FOXO3 haploinsufficiency to cause ovarian failure, FOXO3 mutations or common SNPs are not a common cause of either POF or PA.
Introduction
The median age at menopause is 51 years. However, 1% of women develop ovarian insufficiency prior to the age of 40, and 0.1% prior to the age of 30 (Coulam et al., 1986) . Based on these epidemiologic findings, premature ovarian failure (POF) is usually defined as the development of hypergonadotropic hypergonadism prior to the age of 40. POF results in amenorrhea/infertility, and has systemic consequences (such as reduced bone density) due to sex steroid deficiency (Kalantaridou and Nelson, 2000) . POF has distinct etiologies, including chemo/radiotherapy, galactosemia, X-chromosome abnormalities and autoimmune oophoritis (Aittomaki et al., 1995; Bione et al., 1998; Bione and Toniolo, 2000; Zinn and Ross, 2001; Prueitt et al., 2002; Rossetti et al., 2004) .
However, 90% of POF cases are idiopathic. Case -control studies have shown that affected women have a much higher positive family history of POF than controls, suggesting the existence of as yet unknown hereditary factors influencing POF (Cramer et al., 1995; Pal and Santoro, 2002) . Non-genetic factors (most significantly tobacco smoke) also influence menopausal age, demonstrating that POF may be influenced by a combination of hereditary and environmental influences (Cramer and Xu, 1996) .
Biopsy studies have uniformly found that most POF cases are due to accelerated depletion of primordial follicles (Zarate et al., 1970; Starup and Sele, 1973; Board et al., 1979; Russell et al., 1982) , indicating that POF, like physiologic menopause, in many cases is due to gradual loss and eventual depletion of primordial follicles. This suggests that intrinsic abnormalities of (or damage to) primordial follicles affecting their initial endowment or survival are the unifying pathophysiologic bases for POF. However, the mechanism(s) which could account for accelerated depletion of primordial follicles in idiopathic POF are unknown. Defects in the normal physiologic processes that deplete primordial follicles likely play a major role. Two such mechanisms include: (i) oocyte apoptosis (Tilly, 2001 ) and (ii) primordial follicle activation (PFA), also known as follicle initiation (McGee and Hsueh, 2000) . Because both oocyte apoptosis and PFA occur continually prior to menopause, even subtle defects in either process could, over a woman's lifetime, have a significant cumulative impact on primordial follicle numbers and therefore influence the age at menopause.
We have previously shown that the forkhead transcription factor Foxo3 is a master regulator and potent suppressor of PFA. Loss of Foxo3 function in the mouse leads to POF due to global PFA occurring almost immediately after the completion of primordial follicle assembly within a few days of birth (Castrillon et al., 2003) . These findings raised the possibility that mutations or naturally occurring polymorphisms of the human orthologue FOXO3 (95% sequence identity at the amino acid level) might contribute to POF or to idiopathic primary amenorrhea (PA), a related condition resulting from primordial follicle depletion prior to menarche (Nakano et al., 1982; Timmreck and Reindollar, 2003) . Idiopathic POF and PA may thus be manifestations of fundamentally similar disease processes, with PA representing a more severe phenotype. Finally, heterozygosity for FOXO3 mutations may be biologically significant given that a number of hereditary disorders are due to loss of function mutation of a single forkhead transcription factor allele (haploinsufficiency) (Crisponi et al., 2001; Erickson, 2001 ).
Here we address these questions in both the mouse and human. Lifetime serial breeding assays measuring fecundity and age of menopause were used to test whether Foxo3 is haploinsufficient (i.e. mutation of single allele has phenotypic consequences). This was followed by a comprehensive sequence analysis of the human FOXO3 coding sequence in over 300 women with POF or PA and an evaluation of mutations at this locus to determine whether they contribute to the etiology of these diseases.
Materials and Methods
Serial breeding assay Single-pair matings were established between 3-week-old Foxo3 þ/2 females and Foxo3 þ/þ siblings and six-week-old FVB males to assess fertility. The generation and validation of this Foxo3 null allele (FVB background) has been previously described (Castrillon et al., 2003) . A total of nine matings per genotype were initially established. Breedings were checked daily for births and all offspring were removed by post-natal Day 3 to minimize stress on mothers. A priori, it was established that (i) matings were to be stopped after 12 weeks with no live births, (ii) matings in which the female developed any serious disease or morbidity were to be censored from the analysis (this was the case for one Foxo3 þ/þ female that became lethargic at six months of age; necropsy revealed a large lung adenocarcinoma, a common spontaneous tumor in this genetic background) (Mahler et al., 1996) .
Collection of POF DNA samples Genomic DNA was isolated from human blood leukocytes using standard methods. For the POF samples, ages of the women ranged from 19 to 41. POF and PA cases were obtained in clinics from diverse geographical locations as follows: Italy (n ¼ 93), North America (n ¼ 164), France (n ¼ 25), Germany (n ¼ 10) and South Korea (n ¼ 10). The normal control samples (n ¼ 22) used to identify common sequence variants were of North American origin. All genomic DNA samples were unamplified with the exception of the Italian cohort, which was subjected to one round of whole genome amplification prior to PCR. These studies were performed following approval by review boards at each participating institution, and informed consent was obtained from all patients.
Human FOXO3 sequencing
The two coding exons were amplified from genomic DNA using two sets of primers: exon 1 with FOXO3-E1F: gAGAGGAGAGCG CGAGAG and FOXO3-E1R: aCTCCGACGAATCCGAGAC, Exon 2 with FOXO3-E2F: tATATCATCTGGGTGCTCGGTTTT and FOXO3-E2R: cCCCTCATCCCCATATTGTTATT. Following a 10 min hot start, DNA was amplified for 35 cycles (958C 30 s, 55.48C 30 s and 728C 2 min) in 1Â buffer with 1.5 mM MgCl 2 , 0.25 mM dNTPs, 0.5 mM each primer, 5% DMSO, 50 ng genomic DNA, and 5 U Taq Gold, (Applied Biosystems Inc.) in a total volume of 50 ml. The amplified samples were subjected to agarose gel electrophoresis to ensure single bands and then purified using the High Pure PCR Product Purification Kit (Roche). Samples were sequenced at the UTSW McDermott Sequencing Center using Big Dye Terminator 3.1 chemistry (Applied Biosystems Inc.) with the above primers and run on a 3730xl DNA analyzer (ABI). A third primer was also used to completely sequence exon 2 (FOXO3-E2M: aGTCCAGGACGATGATGCGC). Sequence analysis and heterozygous base calling was aided by Sequencher 4.6 (Genecodes) and Phred/Phrap/Consed (Ewing et al., 1998) . All tracings were also visually inspected for quality assurance.
Site-directed mutagenesis and luciferase assays Mutations in a wild-type FOXO3 cDNA were introduced using the Quick Change Site-Directed Mutagenesis Kit (Stratagene) as per the manufacturer's instructions. The resulting mutants were sequenced to confirm the introduction of the desired mutation. NIH3T3 cells (10 5 /well) were seeded in 24-well plates and cultured for 24 h. The cells were then co-transfected with Firefly luciferase reporter construct (0.5 mg), tk-Rennila luciferase reporter construct (0.25 mg) and FOXO3 control and mutant constructs (0.25 mg). Following 36 h of transfection the cells were lysed in passive cell lysis buffer (100 ml), and luciferase activity was assayed using the Dual-Luciferase Reporter assay system (Promega) as per the manufacturer's instructions.
Results

Foxo3 haploinsufficiency in the mouse
To explore the possibility of Foxo3 haploinsufficiency in mice, we performed lifetime serial breeding assays, a powerful tool for identifying subtle reproductive phenotypes, particularly those that relate to the utilization and survival of primordial follicles. Single-pair matings were established prior to the onset of sexual maturity, and the total lifetime number of progeny for FOXO3 and ovarian failure heterozygous and control sibling females was documented over time (see Materials and Methods). This analysis revealed a small, but statistically significant decrease in fecundity (P ¼ 0.024, t-test) in Foxo3 2/þ females relative to Foxo3 þ/þ siblings (Fig. 1A) . Importantly, plotting the data for individual females showed that this is an overall class effect, and not an incidental finding due to, e.g. a single subfertile female (Fig. 1B) .
Foxo3
2/þ females also showed a trend toward earlier reproductive senescence (5 weeks earlier on average) as determined by comparing maternal ages at the time of their final live births (Fig. 1C) . This is preceded by a gradual decrease in fecundity/ litter size (Fig. 1D) . Notably, however, this is associated with an inverse increase in the number of progeny initially (litter #1); although this effect is small in magnitude, it verges on statistical significance (P ¼ 0.059, one-sided t-test). This observation is consistent with the notion that Foxo3 heterozygosity results in a slight increase in the rate of PFA, particularly as PFA begins at the time of birth and thus has been in effect for 9 weeks by the time of the first litter. Thus in summary, serial breeding assays identified a Foxo3 haploinsufficiency effect not detected in previous morphologic analyses (Castrillon et al., 2003) , demonstrating that mutation of a single Foxo3 allele in mice results in a small but significant decrease in fecundity and acceleration of ovarian failure, consistent with an increased rate of PFA and utilization of primordial follicles.
Case selection and direct PCR sequencing strategy Cases of POF or PA spanned a wide range of ethnicities and geographical regions, including North America, Europe (France, Italy and Germany) and South Korea (see Materials and Methods for details). Idiopathic POF cases (n ¼ 273 total) were defined by standard diagnostic criteria (amenorrhea !4 months prior to the age of 40, persistently elevated FSH in the menopausal range for the local laboratory), and no known cytogenetic abnormalities or history of chemo/radiotherapy. PA cases (n ¼ 29) were similarly defined by standard clinical criteria including absence of known cytogenetic abnormalities. To identify singlenucleotide polymorphisms (SNPs) common in the general population, 22 normal control samples were also sequenced.
The human FOXO3 locus consists of four exons, only two of which are coding. Both coding exons were amplified from genomic peripheral lymphocyte DNA for direct PCR sequencing. To sequence the coding exon 1 PCR product (0.7 kb), the PCR primers were reused for sequencing reactions, whereas the coding exon 2 PCR product (1.5 kb) required sequencing with the PCR primers and an additional internal primer (Fig. 2) . All SNPs were confirmed on repeat PCR reactions.
Identification of SNPs in the FOXO3 locus
Among the total of 273 and 29 POF þ PA samples, 8 SNPs were identified in the coding portions of the two exons (Table I ). All eight polymorphisms were heterozygous in the majority of cases where they were present although some of the more common SNPs were homozygous in a small number of patients. Of the eight SNPs, four are predicted to alter a single amino acid in the FOXO3 protein, whereas the other four are silent and thus not likely to be causally related to POF/PA, although we do note that recent studies have demonstrated that, at least in rare cases, such non-coding changes can have substantial functional impact (KimchiSarfaty et al., 2007) . Of the four coding changes, one variant (p.Ala140Val) was also common in controls, and hence clearly not disease-causing. Only one of the eight SNPs was identified in the Ensembl GeneSNPView database ( Table I) .
The remaining three SNPs resulting in coding changes were rare among the disease samples, being present in only one or two patient samples (in all cases, in POF samples), and not identified in previous studies (Watkins et al., 2006) . None were identified in controls, but this is not statistically significant, nor would analysis of additional disease samples be likely to be informative, given the rarity of these sequence variants. Thus, we subjected these three variants to further computational and functional analyses. Of the three variants, two were predicted by the Polyphen functional impact prediction algorithm to be benign, and one was possibly damaging, while the SIFT and SAPRED algorithms predicted all three variants to be neutral changes. All three variants had low Grantham distance scores, also consistent with neutral changes (Table II) .
To more rigorously explore the potential functional impact of these amino acid variants, we performed site-directed mutagenesis of a wild-type FOXO3 cDNA and measured the activity of each variant through an in vitro system where a luciferase reporter is under the control of a promoter containing eight tandem repeats of the FOXO DNA consensus binding element. In this reporter system, luciferase expression is dependent on FOXO activity (Brunet et al., 1999) . Transfection of NIH3T3 cells with a control wild-type construct revealed baseline levels of activity, whereas a constitutively active variant in which the three AKT phosphorylation sites have been mutated (A3) showed dramatically increased activity. In contrast, a FOXO3 mutant bearing a deletion of the Forkhead DNA binding domain showed negligible activity in this assay system (Fig. 3) . These controls thus fully validated this assay system. However, none of the four amino acid variants assayed (p.Leu94Phe, p.Ala140Val, p.Ala341Thr or p.Leu386Phe) significantly affected FOXO3 activity (Fig. 3) , suggesting that these are rare, functionally normal coding variants. Taken together, this data suggest that FOXO3 coding sequence variants are not a common cause of POF or PA.
Discussion
Previous findings that Foxo3 inactivation in the mouse accelerates ovarian failure represent yet another intriguing connection FOXO3 and ovarian failure between the Foxo forkhead transcription factors and aging, given the known roles of the Foxo factors in organismal stress responses, longevity and survival (Castrillon et al., 2003; Tran et al., 2003) . In considering the possibility of links between FOXO3 sequence variants and human disease, several observations pointed to the possibility that haploinsufficiency might have important phenotypic consequences. Haploinsufficiency for another forkhead transcription factor, FOXL2, results in the autosomal dominant BPES syndrome type I, which is associated with eyelid anomalies and POF. Unlike ovaries from Foxo3 mice and most women with POF, biopsies of BPES ovaries show relatively normal numbers of growth arrested primordial follicles (Fraser et al., 1988) , suggesting that these distantly related forkhead transcription factors have distinct roles in the control of primordial follicle growth. Mutations in FOXL2 have not been identified in idiopathic POF cases (De Baere et al., 2002) . Nonetheless, from a broad perspective, these findings suggested that haploinsufficiency for strong FOXO3 mutations might similarly result in POF. Indeed, several hereditary, autosomal dominant syndromes are due to haploinsufficiency of forkhead transcription factors (Erickson, 2001) . Furthermore, our demonstration of a small but significant Foxo3 haploinsufficiency effect in which Foxo3 heterozygous mice undergo accelerated reproductive senescence also lends credence to the notion that FOXO3 haploinsufficiency in women might accelerate the onset of ovarian insufficiency. The absence of FOXO3 mutations in POF and PA, as documented in this and prior studies (Watkins et al., 2006) , is somewhat surprising, particularly as the POF syndrome in Foxo3 null mice closely resembles human POF. It is possible that FOXO3 mutation has more severe phenotypic consequences in humans than mice (i.e. embryonic lethality). Perhaps more likely, functional redundancies among the human FOXOs mitigate against major phenotypes including ovarian failure. Although the human and mouse genomes share three FOXO orthologs (FOXO1/Foxo1, FOXO3/Foxo3 and FOXO4/ Foxo4), it is also possible that these orthologs serve somewhat different, non-overlapping functions in the two species. In mice, Foxo1 nullizygosity results in embryonic lethality (Hosaka et al., 2004; Paik et al., 2007) , whereas Foxo4 2/2 mice are viable and fertile but exhibit defects in neointimal formation following aortic ligation (Li et al., 2007) . In this regard, it is notable that Watkins et al. (2006) also screened POF patients for mutations in FOXO1 but failed to identify any definitively causal variants, and disease-causing mutations of the FOXOs have not yet been reported (other than as reciprocal translocations in cancer) (Accili and Arden, 2004; Arden, 2007) .
We note that some mutations might abrogate FOXO3 function in vivo yet not have a measurable impact on activity in our in vitro functional assay; e.g. the FOXOs mediate numerous protein interactions not dependent on their function as transcriptional regulators (Greer and Brunet, 2005) . Furthermore, our strategy would not detect FOXO3 copy number alterations that may result in POF/PA, a possibility suggested by our finding of Foxo3 haploinsufficiency in mice (Freeman et al., 2006) . Future efforts to understand the hereditary basis of POF and PA will require systematic efforts to define the molecular components that regulate ovarian follicle formation and growth, followed by screening of large numbers of patients. 
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Figure 3: Identified FOXO3 variants do not affect ability to transactivate reporter gene transcription NIH3T3 cells were transiently co-transfected with FHRE-luc reporter construct (Brunet et al., 1999) , a tk-Renilla luciferase reporter and the appropriate control or experimental FOXO3 cDNA. The cells were incubated for 36 h and luciferase activity assayed.
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